PharmexecMike

🔸Read about 2023 #EmergingPharmaLeader Justin To, Chief Operating Officer, Skeletal Dysplasias and Gene Therapy, @BridgeBioPharma ! 🔸 The recipe for cross-functional collaboration in #drugdevelopment🖋️Mike Hollan ➡️pharmexec.com/view/justin-to… #GeneTherapy #pharmaceutical

🔸Congratulations to our 2023 Emerging Pharma Leaders🔸 Natasha Hernday of @SeagenGlobal Simon Holland of @organonbiosim Justin To of @BridgeBioPharma Frank Watanabe of @ArcutisBio Hanadie Yousef of Juvena Therapeutics Read their profiles here: pharmexec.com/journals/pharm…

🚨Our July issue is LIVE🚨 An insightful discussion with @OtsukaUS' Christine Sakdalan🔷the changing role of #biopharma CFOs🔷Rethinking commission-based deals with independent contractors🔷and so much more waiting right here➡️ow.ly/ra7450JSKKN #pharma #lifesciences

🚨Our June issue is LIVE🚨 The impact of war on drug #supplychain ▪️What makes #hub programs successful?▪️Counting down to 2023 #DSCSA #compliance ▪️and so much more right here➡️pharmaceuticalcommerce.com/view/pharmaceu… #pharma #lifesciences #pharmaceutical #manufacturing

🚨New Podcast Alert🚨 David Sanders, VP of government affairs & policy, @Coherus_Bio , speaks about the firm’s goal of expanding #patientaccess to cost-effective medication, his role with @samscoalition, and much more! 🎙️ow.ly/HrXb50J7ppH #pharma #lifesciences #supplychain

🚨New Podcast Alert🚨 In episode 108, the rest of the PharmExec editorial staff join @PharmExecElaine Quilici and @mschmalfuhs to give more insight into the profiles they've written about the eleven members of our 2022 Emerging Pharma Leaders 🎙️ow.ly/OIOK50J6iQq #pharma